These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 3182962

  • 1. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO, Piraino BH, Mitro R, Chen TC, Segre GV, Greenberg A, Puschett JB.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
    Zanella MT, Silva MC, Peres RB, Ferreira SR, Draibe SA, Vieira JG.
    Braz J Med Biol Res; 1990 Nov; 23(3-4):235-43. PubMed ID: 2094538
    [Abstract] [Full Text] [Related]

  • 4. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
    Rudnicki M, McNair P, Transbøl I, Nielsen B.
    Nephron; 1991 Nov; 58(2):144-9. PubMed ID: 1865969
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
    St John A, Thomas MB, Davies CP, Mullan B, Dick I, Hutchison B, van der Schaff A, Prince RL.
    Nephron; 1992 Nov; 61(4):422-7. PubMed ID: 1501739
    [Abstract] [Full Text] [Related]

  • 7. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD.
    Miner Electrolyte Metab; 1995 Nov; 21(6):398-402. PubMed ID: 8592483
    [Abstract] [Full Text] [Related]

  • 8. Serum ionized calcium, as well as phosphorus and parathyroid hormone, is associated with the plasma 1,25-dihydroxyvitamin D3 concentration in normal postmenopausal women.
    Dawson-Hughes B, Harris S, Dallal GE.
    J Bone Miner Res; 1991 May; 6(5):461-8. PubMed ID: 2068951
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
    Marco MP, Martínez I, Amoedo ML, Borràs M, Saracho R, Almirall J, Fibla J, Fernández E.
    Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
    [Abstract] [Full Text] [Related]

  • 10. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure.
    Martin-Malo A, Rodriguez M, Martinez ME, Torres A, Felsenfeld AJ.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1553-8. PubMed ID: 8856210
    [Abstract] [Full Text] [Related]

  • 11. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N, Amor J, Cambil T, Salgueira M, Sánchez-Palencia R, Páez C, Gómez O, Palma A.
    Nefrologia; 2003 Aug; 23 Suppl 2():64-8. PubMed ID: 12778857
    [Abstract] [Full Text] [Related]

  • 12. Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25-dihydroxyvitamin D in primary hyperparathyroidism?
    Frølich A, Storm T, Thode J.
    Miner Electrolyte Metab; 1996 Aug; 22(4):203-6. PubMed ID: 8807622
    [Abstract] [Full Text] [Related]

  • 13. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.
    Chesney RW, Hamstra AJ, Phelps M, DeLuca HF.
    Kidney Int Suppl; 1983 Nov; 15():S63-9. PubMed ID: 6584678
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F, Fernández MA, Ruiz-Calero R, Cubero J, Aparicio A, Jimenez F, García MC.
    Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
    [Abstract] [Full Text] [Related]

  • 15. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ.
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [Abstract] [Full Text] [Related]

  • 16. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB.
    N Engl J Med; 1987 Jun 18; 316(25):1573-7. PubMed ID: 3035373
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Correlations of serum concentrations of 1,25-dihydroxyvitamin D, phosphorus, and parathyroid hormone in tumoral calcinosis.
    Lyles KW, Halsey DL, Friedman NE, Lobaugh B.
    J Clin Endocrinol Metab; 1988 Jul 18; 67(1):88-92. PubMed ID: 3379139
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.